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Abstract
Herpesvirus latency is generally thought to be governed by epigenetic modifications, but the dynamics of viral chromatin at
early timepoints of latent infection are poorly understood. Here, we report a comprehensive spatial and temporal analysis of
DNA methylation and histone modifications during latent infection with Kaposi Sarcoma-associated herpesvirus (KSHV), the
etiologic agent of Kaposi Sarcoma and primary effusion lymphoma (PEL). By use of high resolution tiling microarrays in
conjunction with immunoprecipitation of methylated DNA (MeDIP) or modified histones (chromatin IP, ChIP), our study
revealed highly distinct landscapes of epigenetic modifications associated with latent KSHV infection in several tumor-
derived cell lines as well as de novo infected endothelial cells. We find that KSHV genomes are subject to profound
methylation at CpG dinucleotides, leading to the establishment of characteristic global DNA methylation patterns. However,
such patterns evolve slowly and thus are unlikely to control early latency. In contrast, we observed that latency-specific
histone modification patterns were rapidly established upon a de novo infection. Our analysis furthermore demonstrates
that such patterns are not characterized by the absence of activating histone modifications, as H3K9/K14-ac and H3K4-me3
marks were prominently detected at several loci, including the promoter of the lytic cycle transactivator Rta. While these
regions were furthermore largely devoid of the constitutive heterochromatin marker H3K9-me3, we observed rapid and
widespread deposition of H3K27-me3 across latent KSHV genomes, a bivalent modification which is able to repress
transcription in spite of the simultaneous presence of activating marks. Our findings suggest that the modification patterns
identified here induce a poised state of repression during viral latency, which can be rapidly reversed once the lytic cycle is
induced.
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Introduction
Herpesviruses are able to establish latent infections, enabling
them to persist for the lifetime of their host [1]. During latency, no
viral progeny is produced; instead, the largely quiescent genome
persists as an extrachromosomal episome in the nucleus of the
infected cell. Unfavorable conditions (e.g. cell stress) may trigger
reactivation of such cells, leading to induction of the lytic cycle and
completion of the viral lifecycle. In a healthy host, latently infected
cells form a reservoir of chronic viral infection which is tightly
controlled by the immune system. However, latently infected cells
may also give rise to disease if the immunological control is lost.
This is especially true for the members of the gammaherpesvirus
subfamily, which are frequently associated with tumors in their
natural host, in particular in immunosuppressed individuals.
Kaposi Sarcoma-associated herpesvirus (KSHV) is etiologically
linked to Kaposi Sarcoma (KS), a tumor of endothelial origin, as
well as at least two lymphoproliferative disorders, primary effusion
lymphoma (PEL) and multicentric Castleman’s disease (MCD)
[2,3,4]. The majority of tumor cells in these malignancies exhibit a
latent gene expression profile which has been extensively studied
in cell lines established from PEL tumors [5,6,7]. These cells
express a very limited contingent of viral genes, including the
latency-associated nuclear antigen LANA (encoded by ORF73)
which permits replication of latent episomes, a viral cyclin D
homologue (v-Cyc/ORF72), a viral homologue of a FLICE-
inhibitory protein (v-Flip) encoded by ORF71 (also termed K13)
and Kaposin (ORF K12), a protein that can stabilize cytokine
transcripts [7,8,9,10,11,12]. All of the above proteins are
translated from alternatively spliced mRNAs transcribed from a
single multicistronic locus; primary transcripts from the locus
furthermore can give rise to 12 virally encoded microRNAs
(miRNAs) [7,13,14,15,16,17,18]. It is thought that, together, these
genes serve to ensure persistence of the latent infection and
survival of the host cell. However, several of the latency genes have
also been shown to exhibit tumorigenic properties in various
experimental systems, supporting the idea that the viral latency
program plays a causative role during onset and/or progression of
KSHV associated tumors.
The viral genes which encode components of the lytic or
productive cycle are transcriptionally silent during latency. This
quiescent state of infection can be overturned by forced expression
of Rta (the product of the ORF50 gene, also termed Lyta), a
homologue of the Epstein-Barr virus (EBV) transactivator Rta
[19,20,21]. Upon expression, Rta acts as a master-switch regulator
which orchestrates the expression of downstream lytic genes,
PLoS Pathogens | www.plospathogens.org 1 June 2010 | Volume 6 | Issue 6 | e1000935leading to massive amplification of viral genomes, followed by
assembly of virions and, ultimately, death of the host cells and
release of viral progeny [20,21,22,23]. How Rta and other lytic
genes are kept silenced during latency is not understood, but it is
very likely that epigenetic modifications play an important role
during this process. This notion is supported by the fact that
treatment of latently infected PEL cells with inhibitors of DNA
methyltransferases as well as histone deacetylases induces lytic
cycle replication, and that lytic cycle induction leads to profound
chromatin rearrangements at several loci [24,25,26,27]. Further-
more, the ORF50 promoter was reported to be subject to DNA
methylation in latently infected PEL cells whereas the latent
ORF73 promoter remained unmethylated, and it has therefore
been suggested that CpG methylation may actively repress Rta
expression during latency [26]. The DNA methylation status of
other regions of the KSHV genome, however, has so far not been
analyzed. Likewise, the current knowledge about global histone
modification patterns during viral latency is very limited. All
studies of latent modification patterns have furthermore been
performed in PEL cells and thus describe the epigenetic status
during fully established latency. However, since the packaged
virion DNA is devoid of DNA methylation as well as histones [28]
and thus epigenetically naı ¨ve, such epigenetic modification
patterns need to be re-established during each round of latent
infection. Especially the early phase of a de novo infection thus
represents a critical phase of the viral lifecycle. We have performed
a comprehensive study of DNA methylation as well as histone
modification patterns across the complete KSHV genome, in both
PEL cells as well as a de novo infected endothelial cell line. We have
observed highly distinct global patterns on the level of both DNA
as well as histone modifications. Such patterns were furthermore
highly similar in PEL cells and stably infected endothelial cells,
suggesting a highly regulated modification program during latency
establishment. However, whereas modified histones could be
readily detected at early timepoints of a de novo infection, DNA
methylation patterns evolved over significantly longer periods of
time, suggesting they do not govern early latency expression
patterns. Our analysis rather suggests that DNA methylation
patterns evolve as a secondary result of the histone modification
patterns, which are established early in the infection. Surprisingly,
in spite of their quiescent state, latent KSHV episomes were also
not devoid of activating histone marks: In fact, such marks
occupied several lytic promoters soon after the de novo infection and
were not stripped from the genomes in long term infected cells.
However, concomitant with the appearance of these modifica-
tions, latent genomes were also subject to profound tri-methylation
of lysine 27 of histone H3 (H3K27), a modification which can
suppress transcription even in the presence of activating marks
[29,30,31]. Thus, latent episomes bear the hallmarks of poised
chromatin, an observation which is in line with the hypothesis that
viral latency represents a meta-stable state of transcriptional
repression which can be quickly reversed once the lytic cycle is
induced.
Results/Discussion
DNA methylation patterns of latent KSHV genomes
In mammals, DNA methylation occurs almost exclusively by
methylation of cytidine residues at CpG dinucleotides and is
generally associated with transcriptional repression (reviewed in
[32]). As methylcytidine is prone to spontaneous deamination, an
evolutionary consequence of DNA methylation is the relative
scarcity of CpG dinucleotides in methylated genomes. In contrast
to most members of the alpha- and betaherpesvirus subfamily, the
majority of gammaherpesviruses show evidence of such CpG
suppression, suggesting that these viruses are subject to DNA
methylation [26]. Furthermore, the genomes of EBV as well as the
rhadinovirus Herpesvirus saimiri (HVS) have been found to carry
methylated CpG motifs at multiple loci in latently infected cells,
suggesting that DNA methylation plays a role in the control of
latent gammaherpesvirus gene expression patterns (reviewed in
[33,34]). So far, analysis of DNA methylation within latent KSHV
genomes has been limited to the promoters of the gene encoding
Rta (i.e. ORF50) and the promoter upstream of ORF73/LANA
which drives expression of the latency gene cluster. While no CpG
methylation was detected in the region of the ORF73 promoter,
the ORF50 promoter was found to be heavily methylated in the
PEL derived cell line BCBL-1 [26]. As promoter activity was
furthermore repressed by DNA methylation in an in vitro assay, it
was suggested that CpG methylation actively suppresses expres-
sion of the lytic switch gene Rta during KSHV latency [26].
However, this hypothesis is complicated by the fact that the same
study also found that the majority of samples from different
KSHV-positive tumor samples did not harbor these methylation
patterns. The authors suggest that their observations may have
been due to the presence of lytic cells, which represent a sub-
population among the mostly latently infected cells in some tumor
types.
Given the absence of comprehensive DNA methylation data for
KSHV, we first sought to determine the global methylation status
of viral episomes in PEL derived cell lines. For this purpose, we
employed the MeDIP (methylated DNA immunoprecipitation)
technique, which is based on the pulldown of methylated DNA
using methylcytidine-specific antibodies [35]. The MeDIP samples
were analyzed on a custom-designed, high-resolution microarray
which covers both strands of the KSHV genome in non-
overlapping, hybridization temperature-optimized 60mers. To
obtain a quantitative measure of the extent of DNA methylation,
we additionally devised positive and negative controls according to
the scheme depicted in Figure 1A. As a negative control, we
employed a bacterially amplified (and hence CpG methylation
free) bacmid clone which carries the complete KSHV genome
Author Summary
A characteristic feature of herpesviruses is their ability to
establish a latent infection during which most of the viral
genes are silenced. As a consequence, no viral progeny is
produced and the host cell remains viable. While the viral
genome may persist in the nucleus of such cells
indefinitely, it retains the ability to re-enter the lytic cycle
and produce new virions if conditions in the cell become
unfavorable. The molecular requirements for the estab-
lishment of latency are poorly understood, but are thought
to depend on epigenetic modifications of the viral
episome. Here, we report a genome-wide screen to
investigate DNA methylation and histone modification
patterns associated with latent infection by Kaposi
Sarcoma-associated herpesvirus (KSHV), a tumor virus
linked to the development of several cancers. We find
that latency is likely to be determined by modifications
commonly associated with genes that are transcriptionally
‘‘poised’’. The promoters of such genes harbor activating
as well as repressive histone marks such that they are
silenced, but they can be rapidly activated upon removal
of the repressive marks. Our findings thus may explain
how KSHV achieves efficient quiescence during latency,
yet retains the potential to quickly revert to a fully active
state upon induction of the lytic cycle.
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be maximally recovered by MeDIP is dependent on the number of
CpG motifs in that sequence. Consequently, the array hybridiza-
tion patterns are a function of the relative degree of methylation as
well as local CpG frequency. To control for such differences we
generated a positive control by in vitro methylation of KSHV
bacmids using the methylase M. SssI, which is specific for CpG
dinucleotides. Restriction analysis confirmed complete methyla-
tion of the bacmid DNA (Fig. 1B). Prior to immunoprecipitation,
the untreated or in vitro methylated bacmid DNA was mixed with
DNA from human cell lines to also control for any signals which
may arise due to cross-hybridization of cellular DNA in the
infected samples. The ratio of viral and cellular DNA was selected
such that it is equal to that typically seen in KSHV-infected PEL
cell lines and corresponds to a viral copy number of approximately
30 genomes per cell. Furthermore, all samples were spiked with a
constant amount of in vitro methylated heterologous DNA, so that
accurate normalization across individual array hybridizations
could be performed. After normalization, the MeDIP values
obtained from the samples or the positive control were corrected
by subtracting the background values from the negative control
(see Material & Methods for details).
To minimize the risk of investigating cell-line specific (and
hence potentially random) modifications, we analyzed the global
DNA methylation pattern of KSHV genomes in three different
PEL-derived cell lines: BCBL1, AP3 and HBL6. The HBL6 line
was originally established from a PEL tumor co-infected with
KSHV and EBV and carries both viruses in a latent state [37].
BCBL1 and AP3 cells are KSHV positive, but negative for EBV.
In Figure 2, we present the results of our analysis of PEL cells,
along with the data obtained from the positive control (upper four
solid graphs in each panel; see also Figure S1 for a more detailed
view with a differentially scaled x-axis). The distribution of local
CpG frequencies across the KSHV genome is also shown (black
line graph). As expected, the positive control yielded a signal
distribution which showed a high degree of correlation with local
CpG content (Pearson correlation coefficient=0.513, see Table 1).
The results from the PEL-derived cell lines revealed that, indeed,
KSHV genomes are subject to profound DNA methylation during
latency. For all three lines, we observed global methylation profiles
which were strikingly similar, with overall correlation coefficients
ranging from 0.593 to 0.724 (Table 1). Furthermore, the profiles
were clearly not a mere function of CpG content, as several
regions showed low levels of DNA methylation in all three PEL
lines, but not the positive control. One such region, extending
approximately from nucleotides (nts.) 127301 to 128901, harbors
the major latency promoter upstream of ORF73. The absence of
methylation in this area is to be expected (and has been noted
before [26]), given the constitutive activity of the promoter in
latently infected cells. However, our analysis revealed several
additional loci which were not (or only poorly) methylated, despite
their (presumable) transcriptional inactivity in latently infected
cells. For example, the region between nts. 9701 and 12601
showed very little methylation in PEL lines compared to the
positive control; this area is centered on the start position of the
gene encoding the DNA polymerase (ORF9), which is exclusively
expressed during the lytic cycle. While the methylation profiles of
the three PEL lines were highly similar, the absolute degree of
methylation was different: Across the complete KSHV genome,
HBL6 reached approximately 88% of the MeDIP signal obtained
for the positive control, followed by AP3 (54%) and BCBL1
(51%).
Figure 1. Experimental design of MeDIP analysis. A: Schematic representation of the experimental setup for the analysis of CpG methylation
patterns. The KSHV episome in infected cells is expected to be partially methylated, as indicated by black and white circles which symbolize
methylated or unmethylated CpG dinucleotides, respectively. Genomic DNA was isolated from such cells and the samples were subjected to
immunoprecipitation using a methylcytidine specific antibody (MeDIP procedure), followed by hybridization of the precipitated samples versus the
input on tiling microarrays. For each probe, an enrichment score ES was calculated, which represents the ratio of MeDIP over input fluorescence
signals. The efficiency of the immunoprecipitation depends on the total number of methylated CpG motifs in a given fragment and ES is thus a
function of the extend of methylation as well as local CpG frequencies. Therefore, to obtain reference values which signify maximum methylation for
each probe, we generated a positive control by subjecting KSHV bacmids to CpG methylation in vitro. The bacmid was mixed with cellular DNA to
simulate the host background and subjected to the same MeDIP procedure as samples from infected cells. Similarly, a negative control of
unmethylated bacmid was prepared to control for cross-hybridization of unspecific background. After normalization of the array data using a spike-in
control (see Material & Methods for details), background-corrected methylation values MS and MP were calculated for each probe by subtraction of
the corresponding negative control value. B: Confirmation of successful in vitro methylation of KSHV bacmids used as a positive control. A bacmid
carrying the complete KSHV genome (BAC36 [36]) was methylated using M.SssI, a methyltransferase specific for CpG dinucleotides. Methylated or
unmethylated bacmids were subjected to restriction digestion using the methylation sensitive enzyme HpaII and its isoschizomer MspI, which cuts
regardless of methylation. Methylated bacmids were resistant to HpaII digestion, signifying complete methylation.
doi:10.1371/journal.ppat.1000935.g001
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PLoS Pathogens | www.plospathogens.org 3 June 2010 | Volume 6 | Issue 6 | e1000935Figure 2. Global DNA methylation patterns of latent KSHV genomes. Global DNA methylation patterns of KSHV genomes in PEL cells (HBL6,
AP3 and BCBL1), long-term in vitro infected endothelial SLK cells (SLKp) or SLK cultures 5 days after de novo infection with KSHV (SLK-5dpi) were
determined by MeDIP array analysis as described in the text. The profile observed for the positive control, consisting of a completely methylated
KSHV bacmid mixed with cellular DNA, is also shown (BacM). CpG methylation values are shown on the y-axis for overlapping 250 bp sequence
windows, shifted along the KSHV genome in increments of 100 bp. Methylation values of individual windows represent the mean of background-
corrected methylation values from all probes matching either strand of the window (see Material & Methods for details). The number of CpG
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specific to PEL cell lines or a general feature of latent genomes, we
next sought to analyze genomes from cells which had established
stable latency after KSHV infection in vitro. While the infection of
non-adherent cells (including B cells) with KSHV in vitro is very
inefficient, a wide variety of adherent cells can be readily infected
by incubating the cultures with supernatants from lytically induced
PEL lines [38]. However, although KSHV rapidly adopts a latent
expression profile in these cultures, most infected cells tend to loose
the viral episomes over the following cell divisions [39]. Only a
small percentage of cells ultimately succeeds in establishing stable
latent episomes, which are then propagated with the same
efficiency as the genomes in PEL cells. Previously, we have
established the SLKp sub-line from in vitro infected SLK cells, a
cell line of endothelial origin [39]. The SLKp line was generated
by pooling seven KSHV-positive single cell clones which had been
isolated from an infected bulk cultures at approximately 65 days
post infection. SLKp cells are stably infected, carry approximately
the same episome copy number as BCBL1 cells (30–40 copies/
cell), and have a strictly latent expression profile [39]. We analyzed
SLKp cells which had been in continuous culture for 6 months,
corresponding to a total time span of approximately 8 months after
the original infection. As shown in Figure 2 (red graph), although
the overall methylation levels in SLKp cells were substantially
lower (reaching approximately 9.6% of positive control levels; note
the differentially scaled y-axis in Figure 2), the observed profile was
indeed highly similar to that seen in PEL cells, with the highest
degree of similarity to BCBL1 cells (correlation coefficient 0.712,
see Table 1). Taken together, these results suggest that the distinct
MeDIP profiles revealed during our analysis are non-random and
represent a characteristic of latent KSHV episomes.
In order to confirm that the relative MeDIP values identified
during our microarray-based analysis are indeed an accurate
measure of CpG methylation levels, we investigated a number of
loci using independent methods. First, based on our analysis of
BCBL1 cells, we chose 3 loci which had registered as being
strongly methylated, and another 3 for which our initial analysis
had suggested the absence of DNA methylation. As shown in
Figure 3A, bulk bisulfite sequencing established near-complete
methylation at the former and absence of methylation at the latter
loci. We selected one of the loci (labeled 1 in Figure 3A) which had
shown differential methylation in PEL and SLKp cells for further
analysis. Figure 3B shows an enlarged representation of the
corresponding section of the KSHV genome, along with the
original MeDIP array data. As shown in Figure 3C, quantitative
real-time PCR amplification of an ,100 bp segment at the center
of the region (indicated by the black bar labeled ‘‘qPCR’’ in
Figure 3B) confirmed the overall lower degree of methylation in
SLKp cells and suggested an intermediate degree of methylation in
AP3 cells, which is in accordance with the array data for this
position. As discussed later, we also investigated de novo infected
SLK cells at 5 days post infection (SLK-5dpi), which showed very
little evidence of methylation. Next, we performed a PCR
amplification of bisulfite converted total DNA from all samples
and subjected the amplified region to digestion with the restriction
enzyme TaqI (combined bisulfite restriction analysis assay,
COBRA). The recognition sequence of TaqI contains a CpG
motif, and as only methylated cytosine residues are preserved
during bisulfite conversion, absence of DNA methylation at the
restriction site leads to TaqI resistance. As shown in Figure 3D,
unmethylated bacmid DNA as well as DNA isolated from KSHV
virions were completely unmethylated and hence resistant to TaqI
restriction. Likewise, DNA from freshly infected SLK cells
remained intact. In contrast, the amplification products from the
in vitro methylated bacmid as well as BCBL1 and HBL6 were
completely cleaved, in agreement with methylation of all 4 TaqI
sites, and the products from AP3 cells and SLKp cells were
incompletely digested, indicating an intermediate level of meth-
ylation. The latter contained a significant amount of undigested
product, suggesting that the material represents a mixture of
methylated and unmethylated DNA, presumably due to clonal
differences in the original single cell clones. We hence determined
the specific sequence of bisulfite converted DNA from two
individual clones, and subjected the remaining samples to bulk
sequencing. The results of this analysis are shown in Figure 3E and
are in perfect accord with our COBRA analysis and MeDIP array
results. Indeed, the two investigated SLKp clones showed
differential methylation patterns at this particular locus, thus
explaining the observed restriction patterns. We hence conclude
that our array analysis accurately reflects CpG DNA methylation
within the KSHV genome.
As noted before, the global methylation patterns in PEL and
SLKp cells were highly similar: If a locus was found to be
methylated in one of the samples it tended to be methylated also in
the others. Only very few loci were methylated in only one sample.
Interestingly, the most prominent locus which showed differential
methylation was a region encompassing nts. 70500 to 71700,
which includes the promoter governing expression of ORF50/
Rta. Our analysis suggested profound methylation in the HBL6
line, but very little or no methylation in AP3, BCBL1 and SLKp
cells (see Figure 2 (second panel) and enlarged depiction of the
ORF50 locus in Figure 4A). This was surprising, as the ORF50
promoter has been previously reported to be abundantly
methylated in BCBL1 cells [26]. To confirm our results, we
performed bulk bisulfite sequencing of the region extending from
the transcriptional start of ORF50 to a position approximately
1100 bp upstream (nts. 70597 to 71681) with DNA isolated from
AP3, BCBL1, HBL6, SLK-5dpi and SLKp and cells (Figure 4B).
dinucleotides which are present in each sequence window are shown at the top. The nucleotide positions and genome map shown at the bottom of
each panel refer to the reference KSHV sequence (NC_009333). Open reading frames and repeat regions are indicated as block arrows and grey
boxes, respectively.
doi:10.1371/journal.ppat.1000935.g002
Table 1. Pearson correlation coefficients of DNA methylation
patterns.
MeDIP
CpG Frequency BacM BCBL1 AP3 HBL6 SLKp
MeDIP
BacM 0.513
BCBL1 0.324 0.427
AP3 0.263 0.407 0.608
HBL6 0.369 0.591 0.593 0.724
SLKp 0.235 0.300 0.712 0.403 0.433
SLK-5dpi 0.297 0.092 0.549 0.334 0.266 0.653
Note: correlation coefficients were calculated according to Pearson from the data
shown in Figure 2. All data points are given in Dataset S1.
doi:10.1371/journal.ppat.1000935.t001
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products from BCBL1, SLKp and HBL6 cultures to COBRA
analysis (Figure 4C). The results clearly confirmed our MeDIP
results and revealed near complete CpG methylation of the
ORF50 promoter region in the HBL6 line, but no or only sporadic
methylation in all other cells. We currently do not know the reason
for the different BCBL1 methylation patterns detected in our study
and that performed by Chen et al. [26]. It is possible that Chen
and colleagues employed a different sub-clone of the BCBL1 line,
or that the lines may have diverged while being cultured in the two
Figure 3. Verification of MeDIP microarray results. Bisulfite sequencing (BS), COBRA analysis and real-time qPCR were used to confirm KSHV
DNA methylation profiles at select loci. A: Three loci for which our MeDIP analysis had indicated profound methylation, and three loci which were
predicted to be unmethylated were analyzed by bisulfite sequencing of BCBL1-derived DNA. The global BCBL1 MeDIP methylation profile and the
location of sequenced regions are shown for reference at the top. The results of the bisulfite sequencing are shown underneath, where closed and
open circles indicate methylated and unmethylated CpG motifs, respectively. The nucleotide positions indicate the position of the first and the last
CpG motifs within the KSHV reference genome (NC_009333). B–E: Confirmation of DNA methylation profiles at the genomic ORF23 locus in PEL cells
(HBL6, AP3 and BCBL1), long-term in vitro infected endothelial SLK cells (SLKp), SLK cultures 5 days after de novo infection (SLK-5dpi), in vitro
methylated or unmethylated KSHV bacmids (BacM and Bac, respectively), and virion DNA. The methylation profiles of the samples investigated by
MeDIP are shown in B. Black lines indicate the regions for which COBRA analysis and bisulfite sequencing of genomic DNA, or real-time qPCR of
MeDIP samples were performed. C: Real-time qPCR was performed to quantify immunoprecipitated DNA from three independent MeDIP
experiments. Values were calculated as percent of the input and were normalized to an internal control consisting of methylated plasmid DNA
(pCR2.1) spiked into each sample prior to MeDIP. D+E: the region indicated in B was PCR-amplified from bisulfite converted DNA and subjected to a
COBRA assay (D) or bisulfite sequencing (E). Cleavage of bisulfite converted DNA at the TaqI sites indicated by arrows requires methylation of the
corresponding CpG motif. The CpG profiles as shown in E were determined by bulk sequencing reactions except for the samples labeled SLKp #1
and #2, which represent two individual clones from the SLKp line.
doi:10.1371/journal.ppat.1000935.g003
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similar (but not identical) to those described by Chen et al., and
thus an agreement between both studies is that such patterns can
principally evolve in PEL cells. However, regardless of the reasons
for the different findings, our results clearly show that methylation
of the ORF50 promoter is not a principal requirement for the
maintenance of latency in PEL cells or in vitro infected endothelial
cells lines. As the majority of cells in PEL and KS tumors are
latently infected with KSHV, our findings may also provide an
alternative explanation for the observation that the ORF50
promoter was found to be not or only poorly methylated in the
majority of clones derived from such tissues [26].
SLKp cells exhibited global methylation patterns which were
near-identical to those seen in the BCBL1 line, but were
characterized by a significantly lower absolute level of DNA
methylation (approximately 1/5th of that seen in BCBL1 cells).
This observation suggested to us that DNA methylation of KSHV
episomes may progress slowly over time; hence the lower overall
Figure 4. DNA Methylation at the ORF50 promoter. A: Methylation profiles of KSHV infected cells at the ORF50 promoter (see legend to
Figure 3 for abbreviations). The region investigated by COBRA and bisulfite sequencing is indicated by the black bar above and hashed lines
underneath the graph. B: Results of bisulfite sequencing of genomic DNA from BCBL1, HBL6 or SLKp cells. Closed and open circles indicate
methylated and unmethylated CpG motifs, respectively. Numbers above each circle indicate the position of the motif relative to the ORF50
transcriptional start. The nucleotide positions shown underneath indicate the position of the first and the last CpG motifs within the KSHV reference
genome (NC_009333). The position of TaqI restriction sites in bisulfite converted DNA is indicated by arrows (conservation of the sites requires
methylation of the corresponding CpG motif). The black bars labeled ‘‘Fragment I’’ and ‘‘II’’ represent the two overlapping PCR fragments which were
amplified and sequenced, and which were further analyzed by COBRA as shown in C.
doi:10.1371/journal.ppat.1000935.g004
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period of time (approx. 8 months, see above) that has elapsed since
the SLKp cells were originally infected. We therefore analyzed
SLK cultures which had been freshly infected with KSHV. We
choose a time point of 5 days post-infection for our analysis; at this
time point, the cultures have adopted latent expression patterns
and sporadic lytic cells are found only at very low frequency
(,0.01%) [38,39]. Quantitative RT-PCR (Figure 5A) and
immunofluorescence analysis (Figure 5B) confirmed efficient
infection and absence of lytic gene expression (note that the
relatively high basal levels of lytic ORF50 and ORF59 transcripts
in latent BCBL1 cultures (Figure 5A, top panel) can be
significantly upregulated by lytic cycle induction (bottom panel);
they stem from the small number (approximately 0.3%, see Figure
S4) of spontaneously reactivating cells present in uninduced
BCBL1 cultures). Indeed, our array-based MeDIP analysis of
global DNA methylation patterns of SLK-5dpi cultures revealed
very little DNA methylation at this early time point of infection
(see graphs labeled SLK-5dpi in Figures 2, 3B and 4A), reaching,
on average, less than 1% of the levels observed for the positive
control. DNA methylation was also virtually absent from the
ORF50 promoter, in spite of the fact that the infected cultures had
established a strictly latent infection. These findings support our
hypothesis that, although DNA methylation may reinforce latent
gene expression patterns at late timepoints of infection, ORF50
promoter methylation is principally not required to abolish or
prevent Rta expression during KSHV latency.
Histone modification patterns of latent KSHV episomes
Given the absence of DNA methylation in our SLK-5dpi
samples, we deemed it unlikely that this modification governs early
KSHV latency expression patterns, and hypothesized that such
patterns might rather be governed by histone modifications.
Herpesvirus genomes are known to become rapidly chromatinized
[40] after host cell entry, and the deposition of histone
modifications is therefore expected to represent a much more
dynamic process than DNA methylation. To investigate this
hypothesis, we performed chromatin immunoprecipitation (ChIP)
experiments from BCBL1, SLKp cells or de novo infected SLK
cultures and analyzed the precipitated DNA on our tiled
microarrays using standard ChIP-on-chip protocols (see Material
& Methods for details). First, we investigated the distribution of
two modifications which are commonly associated with active
chromatin, using antibodies which are specific for Histone H3
acetylated at lysine 9 and/or 14 (H3K9/K14-ac), or H3 molecules
which are tri-methylated at lysine K4 (H3K4-me3). As shown in
Figure 6 (see also Figure S2 for a more detailed view), in BCBL1 as
well as SLKp cells we observed global modification patterns which
were highly similar when comparing any pairwise combination of
either histone modification or cell line, with correlation coefficients
ranging from 0.709 to 0.894 (Table 2). Furthermore, investigation
of H3K4-me3 patterns in SLK-5dpi cultures showed that these
patterns were indeed already fully established 5 days after de novo
infection. Comparison with the previously observed CpG
methylation patterns revealed a marked negative correlation
between these histone modifications and DNA methylation, as
most of the regions which had been found to be poorly methylated
in BCBL1 or SLKp cells compared to the positive control showed
abundant deposition of active histone marks. In accordance with
the overall higher degree of DNA methylation, this negative
correlation was most obvious in BCBL1 cells (Pearson correlation
coefficient=20.530, see Table 2), but could also be clearly
observed in SLKp cells (correlation coefficient=20.263). Inter-
estingly, while the highest density of CpG motifs within the KSHV
genome is found at the terminal repeats (TR, see rightmost region
of the KSHV map), this is also the region which showed the
highest levels of H3K9/K14-ac and H3K4-me3 enrichment. The
latter is in agreement with the observation that, in spite of the high
Figure 5. Latent KSHV expression patterns of SLKP and de novo infected SLK cells. A: Expression of select latent (ORF71, ORF73) and lytic
(ORF50, ORF59) transcripts was analyzed by quantitative RT-PCR in BCBL1 cells, long-term infected SLKP cells and de novo infected SLK cultures at day
5 post infection (SLK-5dpi). Levels were normalized to represent expression relative to ORF73, which is expressed during the latent as well as the lytic
cycle. Compared to BCBL1, SLK-5dpi cells show little expression of lytic antigens, and expression was undetectable in SLKp cells. The detection of lytic
transcripts in latent BCBL1 cultures is due to the low percentage (less than 1%) of cells which undergo spontaneous lytic reactivation. The percentage
of lytic cells and thus transcript levels can be increased by treatment such as sodium butyrate (lower panel). Spontaneously reactivating cells are
completely absent from SLKp cells, which is in accordance with the lack of detectable lytic gene expression. B: Immunofluorescence staining of SLK-
5dpi cultures for LANA, the product of ORF73. DAPI staining is shown in the lower panel. More than 90% of the cells tested positive for LANA, while
expression of the lytic DNA polymerase processivity factor encoded by ORF59 could be detected in less than 0.01% of cells (compare also left column
in Figure 9F).
doi:10.1371/journal.ppat.1000935.g005
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from this region (Figure 2). In fact, in bulk bisulfite sequencing
reactions, we were unable to identify any DNA methylation within
the terminal repeats in SLKp or BCBL1 cells (data not shown).
Hence, our data indicate that local deposition of active histone
marks early during KSHV infection prevents the acquisition of
DNA methylation over the ensuing cell divisions, ultimately
leading to the establishment of the global methylation patterns as
shown in Figure 2.
While it may account for the evolution of the observed DNA
methylation patterns, the distribution of H3K9/K14-ac and
H3K4-me3 modifications provides no immediate explanation for
Figure 6. Global patterns of H3K9/K14 Acetylation and H3K4 tri-methylation on latent KSHV genomes. Global patterns of H3K9/K14
Acetylation (H3K9/K14-ac) of KSHV genomes in BCBL1 and SLKp cells, as well as H3K4 tri-methylation (H3K4-me3) patterns in BCBL1, SLKp and SLK
cultures at 5 days post infection (SLK-5dpi) were analyzed by ChIP-on-chip assays as described in the text. Values shown on the y-axis represent
relative enrichment of normalized signals from the immunoprecipitated material over input, calculated for overlapping sequence windows of 250 bp
by averaging the values from all matching probes, as described in the legend to Figure 1 and the Material & Methods section. See legend to Figure 1
for explanation of map elements displayed at the bottom of each panel.
doi:10.1371/journal.ppat.1000935.g006
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present on many loci which are transcriptionally inactive during
latency. Notably, this also includes the ORF50 promoter, a finding
which is in accordance with the absence of DNA methylation at
this location in BCBL1 as well as SLKp cells. We therefore
reasoned that latency may be determined by the presence of
repressive marks rather than the absence of activating ones.
Therefore, we analyzed two modifications commonly associated
with silent chromatin: Tri-methylation of lysine 9 of histone H3
(H3K9-me3), which is a hallmark of constitutive heterochromatin,
and tri-methylation of lysine 27 (H3K27-me3), a modification
which is typically seen in facultative heterochromatin. As shown in
Figure 7 (lower graphs in each panel; see also Figure S3 for a more
detailed view), in both BCBL1 and SLKp cells the H3K9-me3
modification was mainly restricted to two consecutive regions of
the viral genome, spanning approximately nts. 33000 to 46000
(ORF19-ORF25) and 100400 to 114400 (ORF64- ORF67). Both
of these regions had shown relative poor occupancy with
acetylated histones in our previous assay (see Figure 6), which is
in agreement with the fact that these modifications in general are
mutually exclusive. While the H3K9-me3 modification was most
prominently detected in BCBL1 cells, SLKp cells did display a
markedly less distinct pattern, and the modification was barely
detectable in SLK-5dpi cultures. The ORF50 promoter was
devoid of trimethylated H3K9 in all samples. Hence, H3K9-me3
is unlikely to be a major regulator of latent gene expression, at least
not in the early phase of infection when latency is first established.
Our findings are in agreement with a previous study that had
investigated a number of select loci in ChIP experiments, and had
found little to no H3K9 methylation at any of them [41].
Next, we analyzed the distribution of the H3K27-me3
modification across the viral genome. H3K27 tri-methylation is
carried out by EZH2, the enzymatic subunit of the polycomb
PRC2 complex, leading to the recruitment of polycomb PRC1
complexes and thus gene silencing [29,30,31,42,43,44]. Tri-
methylation of H3K27 has been shown to play important roles
in developmental and differentiation processes, cell cycle regula-
tion, mammalian X chromosome inactivation, stem cell identity
and cancer [31]. One characteristic of H3K27 methylation is that,
in contrast to H3K9-me3, it can occupy promoters concurrently
with activating modifications, specifically H3K4-me3 or H3K9-ac.
Such regions are termed ‘‘bivalent’’ domains and have been found
to be specifically enriched in embryonic stem cells, where they
often occupy promoters which encode key factors involved in
developmental regulation [42]. The presence of H3K27 methyl-
ation keeps these promoters silent in undifferentiated cells, but the
chromatin remains in a ‘‘poised’’ state due to the simultaneous
presence of activating marks. Decreasing levels of H3K27-me3
during the onset of differentiation allows such promoters to rapidly
revert to an active state, hence further commiting the cell to
terminal differentiation [42]. As shown at the top of each panel in
Figure 7, our analysis revealed that latent KSHV episomes in the
BCBL1 and SLKp lines as well as SLK-5dpi cells were subject to
abundant H3K27 tri-methylation. The modification was detected
virtually across the complete genome, although most regions
which had been found enriched in H3K9/K14-ac and H3K4-me3
modifications tended to be tri-methylated at H3K27 to a lesser
extend (compare with Figure 6, see also correlation coefficients in
Table 1). A number of loci, however, displayed the hallmarks of
bivalent chromatin, i.e. simultaneous presence H3K27-me3 and
activating marks. Interestingly, the ORF50 promoter featured
prominently among these regions, whereas the major latency
promoter upstream of ORF73 showed very little or no H3K27 tri-
methylation in all three samples. Importantly, in contrast to
H3K9-me3, the H3K27-me3 patterns were already present 5 days
after de novo infection of SLK cultures. This also includes the
ORF50 promoter, and our data thus suggest that a poised state of
repression is imposed upon the ORF50 promoter early during the
establishment of latency. Interestingly, two studies have recently
found this modification to be present on herpes simplex virus
genomes during latent infection in dorsal root or trigeminal
ganglia [45,46]. Although only a small number of select promoters
were investigated, this may indicate a general role for this
modification during herpesvirus latency.
Table 2. Pearson correlation coefficients of DNA methylation and histone modification patterns.
MeDIP H3K9/K14-ac H3K4-me3 H3K27-me3 H3K9-me3
BCBL1 SLKp SLK-5dpi BCBL1 SLKp BCBL1 SLKp SLK-5dpi BCBL1 SLKp SLK-5dpi BCBL1 SLKp
H3K9/K14-ac
BCBL1 20.539 20.321 20.292
SLKp 20.384 20.246 20.189 0.848
H3K4-me3
BCBL1 20.530 20.341 20.262 0.894 0.801
SLKp 20.263 20.180 20.095 0.709 0.824 0.772
SLK-5dpi 20.291 20.119 20.079 0.660 0.822 0.676 0.794
H3K27-me3
BCBL1 0.107 0.016 20.013 20.459 20.565 20.450 20.428 20.528
SLKp 0.458 0.210 0.141 20.430 20.508 20.376 20.406 20.482 0.619
SLK-5dpi 0.414 0.233 0.183 20.501 20.613 20.449 20.415 20.477 0.593 0.812
H3K9-me3
BCBL1 0.663 0.413 0.303 20.379 20.278 20.267 20.131 20.203 20.093 0.412 0.331
SLKp 0.406 0.397 0.230 20.263 20.206 20.151 20.069 20.095 20.055 0.218 0.215 0.615
SLK-5dpi 0.081 0.107 0.197 20.061 20.030 0.024 0.123 0.269 20.009 0.078 0.302 0.130 0.185
Note: correlation coefficients were calculated according to Pearson from the data shown in Figures 2, 6 and 7. All data points are given in Dataset S1.
doi:10.1371/journal.ppat.1000935.t002
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PLoS Pathogens | www.plospathogens.org 10 June 2010 | Volume 6 | Issue 6 | e1000935Figure 7. Global patterns of H3K27 and H3K9 tri-methylation on latent KSHV genomes. Global patterns of histone H3 tri-methylated at
lysine 27 (H3K27-me3) or 9 (H3K9-me3) on KSHV genomes in BCBL1, SLKp cells as well as SLK cultures at 5 days post infection (SLK-5dpi) were
analyzed by performing ChIP-on-chip assays as described in the text. Values shown on the y-axis represent relative enrichment of normalized signals
from immunoprecipitated material over input, calculated for overlapping sequence windows of 250 bp by averaging the values from all matching
probes, as described in the legend to Figure 1 and the Material & Methods section. See legend to Figure 1 for explanation of map elements displayed
at the bottom of each panel.
doi:10.1371/journal.ppat.1000935.g007
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multiple copies of the viral episome, it may appear possible that
the simultaneous detection of activating marks and the H3K27-
me3 modification could be due to the existence of distinct, but
separate episome populations. We think this is very unlikely, as we
have observed the same patterns in BCBL1 cells and in vitro
infected SLK cells. Thus, if distinct populations exist, they would
have to be re-established in the exact same stoichiometry upon a de
novo infection. However, to also directly investigate the presence of
bivalent histone modifications, we have performed a sequential
ChIP from BCBL1 cells, followed by qPCR amplification of two
regions within the ORF50 promoter. As controls, we investigated
the latent promoter upstream of ORF73 (which exclusively carries
activating marks) and a region within the coding region of ORF21
(which is subject to the H3K27-me3 modification, but is devoid of
H3K9/K14-ac and H3K4-me3 marks). The location of the
amplified regions and their histone modification profiles are
depicted in Figure 8A. As shown in Figure 8B, when the first
round of immunoprecipitation was carried out with an antibody
specific for H3K9/K14-ac, the sequential ChIP using a H3K27-
me3-specific antibody recovered material only from the ORF50
promoter, but neither of the two control regions. To confirm these
results in the reverse direction, we also performed the first round of
immunoprecipitation using the H3K27-me3-specific antibody and
used a H3K4-me3 antibody for the second immunoprecipitation
to probe for the presence of activating marks (Figure 8C). Again,
while the ORF21 region was recovered in the first round of ChIP,
only the ORF50-specific sequences registered in both immuno-
precipitation experiments, thus demonstrating bivalent modifica-
tion of this promoter.
If H3K27-me3 contributes to the silencing of the ORF50
promoter, these marks should also diminish upon lytic cycle
induction. We therefore monitored the levels of H3K27-me3
during reactivation from latency. Indeed, sodium butyrate
treatment of BCBL1 cells resulted in a progressive loss of
H3K27-me3 at the ORF50 promoter, with a reduction to
approximately 50%, 20% and 5% of the original levels after 24,
48 and 72h of treatment, respectively (Figure 8D). While this
observation suggested efficient removal of H3K27-me3, the
magnitude of the effect at 48h and 72h post induction was
surprising, given that the treatment only reactivates about 20% of
all cells in the cultures (as judged by staining for the late gene
product ORF59). A possible explanation for this observation is
that the rapidly increasing numbers of replication products (which
are epigenetically naive) exaggerate the effect at late time points, as
they will lead to a relative increase in the percentage of unmodified
episomes within the cultures. However, the 24h time point
precedes the replication phase and accumulation of newly
synthesized/packaged genomes thus cannot be responsible for
the H3K27-me3 decrease observed early after induction. To
further substantiate this assumption, we also monitored H3K9/
K14-ac levels at the ORF50 promoter. We reasoned that, if the
above is correct, prior to the onset of DNA replication we should
first see an increase of the histone acetylation levels, followed by a
decline as more and more replicated genomes accumulate. As
shown in Figure 8D, this is precisely what we observed. Thus,
upon lytic cycle induction, a reduction of H3K27-me3 and an
increase of H3K9/K14-ac levels occur simultaneously at the
ORF50 promoter and precede the DNA replication phase.
In order to investigate whether a reduction of H3K27-me3 also
results in an increase of the number of lytically reactivated cells in
the absence of chemical inducers, we next generated BCBL1 and
SLK cells which were stably transduced with a retrovirus that
expresses the H3K27-me3-specific demethylase JMJD3 [47]. After
antibiotic selection of the cultures for 12 days, the SLK cells were
additionally infected with KSHV and analyzed 5 days later. In
both lines, while the ectopically expressed JMJD3 protein was
barely detectable on western blots (data not shown), we
nevertheless observed a reduction of total cellular H3K27-me3
levels of at least 50% (Figure 9A). The reduction was less
pronounced on the ORF50 promoter, which still exhibited about
70% and 80% of the H3K27-me3 levels seen in the vector controls
of BCBL1 and SLK-5dpi cells, respectively (Figure 9B). However,
as shown in Figure 9C, despite of the moderate degree of this
reduction, both cultures showed a marked increase in the overall
levels of ORF50 transcription, which reached approximately twice
the values as in the control cultures. When we stained the JMJD3-
transduced BCBL1 cultures for the late gene product ORF59,
(Figure 9D) we furthermore observed a twofold increase in the
percentage of spontaneously reactivated cells in the JMJD3-
transduced BCBL1 cells (,0.6%, compared to 0.3% in the control
cultures). In addition, the JMJD3-transduced cells were also more
responsive to lytic cycle induction by sodium butyrate treatment,
resulting in the reactivation of 30% of the cultures (compared to
approximately 20% in the control cultures; Figure 9E).
In comparison to PEL lines, SLK cells as well as most other de
novo infected adherent cell lines exhibit an extremely low
percentage of spontaneously reactivated cells [38,39]. Such cells
do also not respond to chemical inducers which reactivate PEL
cells (e.g. phorbol esters), although the lytic cycle can be induced
by ectopic Rta/ORF50 overexpression [38]. Their low frequency
notwithstanding, in addition to the elevated ORF50 transcript
levels we also observed an approximately threefold increase of the
number of spontaneously reactivated cells in JMJD3-transduced
SLK-5dpi cultures (Figure 9E). Taken together, the above data
suggest an important role for the H3K27-me3 histone modifica-
tion during latent infection with KSHV.
While our analysis has revealed highly distinct patterns of DNA
and histone modifications, the question remains which factors
determine such patterns. The molecular requirements for the
recruitment of PRC2/EZH2 methyltransferase complexes in
mammals are poorly understood, and so far no simple sequence
motifs recognized by these complexes have been described. The
results from our early infected SLK cultures would seem to
indicate that PRC2/EZH2 complexes are recruited to KSHV
genomes in a more global fashion. However, it is also possible that
the modification is initially established at a small number of loci
and rapidly spreads to neighboring regions during the earliest
stages of a latent infection. Whatever the mode of deposition, loci
with lower levels of H3K27-me3 are ultimately confined to those
regions which carry activating H3K9/K14-ac and H3K4-me3
marks which, clearly, are present not only on latency promoters.
Two independent studies have noted the presence of such marks in
latent cultures before, using ChIP in conjunction with either PCR
for a number of select loci, or a global promoter microarray
[24,41]. Overall, the data from our high-resolution tiling arrays
are in very good agreement with the findings reported in both
studies. However, while Ellison and colleagues hypothesized that
the detection of these marks may have been due to a low
percentage of cells which undergo spontaneous reactivation, our
study clearly shows that they are a hallmark of latent episomes:
First and foremost, the patterns were not only detected in BCBL1
cells, but also in SLKp cultures, which are strictly latent and do
not harbor any spontaneously reactivated cells. Second, for a low
percentage of reactivated cells to leave a prominent footprint in
the histone modification profile of the total population, one has to
assume that they contain a disproportional high number of
episomes which carry the lytic marks. Given the high copy number
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reasonable assumption (provided that the lytically replicated
genomes inherit the parental modification patterns, and that
histones are removed only immediately before packaging).
However, this does not apply to DNA methylation (which is
absent from replicated virion DNA). The fact that the global CpG
methylation patterns observed in our study show a marked
negative correlation with the activating histone marks thus strongly
argues for their presence on latent episomes.
So what signals trigger the initial recruitment of activating
marks at the earliest timepoints of infection? While this is,
ultimately, an issue which will have to be resolved in future studies,
Figure 8. Bivalent histone modification patterns at the ORF50 promoter are reversed upon induction of the lytic cycle. A: Profiles of
H3K9/K14-ac (blue), H3K4-me3 (red) and H3K27-me3 (black) histone modifications at the ORF21 (left), ORF50 (center) and ORF73 (right) loci of BCBL1
cells. Black bars indicate the location of regions amplified by quantitative PCR in the sequential ChIP and lytic reactivation experiments shown in B–D.
B, C: Sequential ChIP experiments carried out with antibodies directed against H3K9/K14-ac and H3K27-me3 during the first and second rounds of
immunoprecipitation, respectively (B), or with antibodies against H3K27-me3 during the first ChIP, followed by H3K4-me3 specific antibodies for the
second immunoprecipitation (C). For the first as well as the second round of immunoprecipitation, numbers on the y-axis indicate the percentage of
recovered material relative to the total starting material (i.e., the amount of DNA which was used as the input during the first ChIP). D: Reversal of
H3K27-me3 marks at the ORF50 promoter upon lytic reactivation. BCBL1 cells were treated with 0.3mM sodium butyrate to induce the lytic cycle.
ChIP experiments were performed at the indicated time points to monitor changes in H3K27-me3 and H3K9/K14-ac modification patterns, using
quantitative PCR with primers specific for the p50 2800 region as shown in A.
doi:10.1371/journal.ppat.1000935.g008
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have performed genome-wide screens for Rta binding sites
[24,48], we noticed that a surprising number of sites mapped
within or very close to the loci which were found to be enriched for
activating histone marks during our investigation (see Figure S5).
Interestingly, Rta is known to be expressed for a brief period of
time within the first few hours of a de novo infection, before latency
ensues [49]. Therefore, one attractive hypothesis is that binding of
Rta may trigger the initial modification of H3K9/K14 and H3K4
at these sites. The onset of widespread H3K27 methylation then
may lead to the silencing of the ORF50 promoter, establishing a
poised state of repression which can be easily reverted upon
reactivation. However, while this model may explain the initial
deposition of activating marks, it does not provide a satisfactory
explanation for their maintenance during the later stages of viral
latency. So far, there is very little evidence for the propagation of
activating histone marks through cell divisions; rather, it is thought
that their preservation requires continuous transcriptional initia-
tion. In contrast to DNA methylation or polycomb-associated
H3K27-me3 marks, H3K9/K14-ac and H3K4-me3 modifications
are therefore not considered inheritable (and, therefore in a strict
sense also do not represent epigenetic modifications). Thus, even if
Rta is indeed responsible for the initial establishment of H3K27-
me3 and H3K9/K14-ac marks, due to its rapid eradication upon
establishment of latent expression patterns it cannot be responsible
for their long-term maintenance. One possible explanation is that
these loci represent preferred binding sites not only for Rta, but
also for constitutively expressed host transcription factors. In this
scenario, host factors could sustain the poised state of repression at
H3K27-me3 enriched promoters, but additional stimuli would be
required to return them to an active state. There are, however,
also a few loci which are rich in H3K9/K14-ac and H3K4-me3
marks, but display very little H3K27 tri-methylation or DNA
methylation. These include not only the constitutively active
latency promoter upstream of ORF73 as well as the locus
encoding the KSHV miRNA-cluster, but also ORFs K5/K6/K7/
nut-1, the region upstream of three of the four vIRFs (vIRF1/K9,
vIRF-3 and vIRF-4) and the complete K15 gene region at the
right end of the viral genome. vIRF-3 (also termed latency-
associated antigen 2, LANA2) is known to be expressed in latent
PEL cells [50] and K15 (which encodes the latency associated
membrane protein/LAMP) has been originally identified as a
latently expressed gene, although its expression is significantly
upregulated during the lytic cycle [51]. Since the region
immediately upstream of the K1 gene at the left side of the
KSHV genome as well as the terminal repeats (shown only to the
right of the map in Figures 2, 5 and 6; as the episome is circular
they however also flank the left terminus of the genome) are also
highly enriched in activating marks but display very little H3K27-
me3, our data also support a previous report of K1 expression in
latently infected cells [52]. However, as K1 transcription is
strongly upregulated in lytic cells and LANA has been found to
repress K1 gene expression [53], whether K1 is indeed expressed
at significant levels during latency is currently unclear. Interest-
ingly, the region upstream of the K2 gene also displayed a high
ratio of activating vs. repressive marks in BCBL1 cells (which is less
pronounced in SLKp or SLK-5dpi cells). K2 encodes v-IL6, a
viral homologue of IL6 which supports B cell growth and blocks
interferon responses [54,55]. While v-IL6 has been reported to be
expressed in latently infected PEL cells [54,56], similar to K1 its
expression is strongly upregulated by lytic cycle induction and it
thus remains controversial whether it represents a latent gene.
Although latent transcripts of unknown promoter origin have
also been identified in the broader region encompassing ORFs K4
to K7 [57], most of the remaining genes so far have not emerged
as being latently expressed in experimental systems [58]. If
continuous transcriptional initiation is required to maintain
H3K9/K14-ac and H3K4-me3 marks, then additional factors
may exist which stall RNA polymerase II at these loci.
Alternatively, it is possible that above genes are transcribed during
latency only at low level, or that their mRNAs are rapidly turned
over such that they do not accumulate. Transactivation by Rta as
well as transcript stabilization by other lytic gene products (e.g. the
Figure 9. Consequences of JMJD3 expression in BCBL1 and de
novo infected SLK cells. A: Reduction of global H3K27-me3 levels in
BCBL1 (left) or SLK cells (right) after 2 weeks of transduction with a
JMJD3-expressing retrovirus (right lanes in each panel) or with an
empty control virus (left lanes). Western blots were simultaneously
stained with antibodies specific for H3K27-me3 as well as actin. B–F:
Analysis of JMJD3-transduced BCBL1 cells, as well as JMJD3-transduced
SLK cells after 5 days of infection with KSHV. B: H3K27-me3 status of the
ORF50 promoter, as judged by ChIP analysis followed by real-time qPCR
with primers amplifying the p50 2800 region shown in Figure 8A.
Values are shown as relative levels in JMJD3-transduced compared to
the control cells, which were set to 100%. C: ORF50 transcription as
judged by quantitative PCR. Values are given as fold transcript levels in
JMJD3-transduced cells compared to control cultures (set to 1). D and
F: Percentage of spontaneously reactivating cells (as judged by
immunofluorescence staining for the product of ORF59) in JMJD3
expressing BCBL1 (D) or SLK (F) cells, or the corresponding control
cultures. E: Percentage of ORF59 positive cells after induction of BCBL1
cells with sodium butyrate for 72h.
doi:10.1371/journal.ppat.1000935.g009
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genes once the viral genome is committed to productive
replication. Taken together, our data thus provide a rationale
for the observation that some of the above genes have been found
to be expressed at low level in latent cultures. Importantly, they
may also help to understand how the host environment may
modulate the latent gene expression program. For example, IFN-a
treatment of PEL cells has been shown to result in the
transactivation of the K2 promoter via IFN-stimulated response
element (ISRE) sequences [55]. It has been suggested that this
enables the virus to sense innate immune responses and modify its
gene expression in order to block them, a model which is strongly
supported by the observation that the K2 promoter appears to be
already primed for expression in latently infected PEL cells.
Finally, there is also the question of the role of the profound
DNA methylation which occurs at later stages of viral latency. It
appears likely that these patterns are established as a consequence
of the continuous presence of EZH2/PRC2 repressor complexes
on viral DNA, as such complexes have been shown to directly
recruit DNA methyltransferases (DNMTs) [59]. The absence of
DNA methylation at loci which are devoid of H3K27-me3 would
support this conclusion. Another contributing factor could be the
delayed appearance of constitutive heterochromatin marks: While
H3K9-me3 is restricted to a few regions, it may nevertheless
support the recruitment of DNMTs to the viral genome (this may
be especially the case at the ORF64 locus, which displays the
highest levels of H3K9-me3 but only moderate levels of H3K27-
me3). What are the functional consequences of DNA methylation?
Currently, this is a question that is difficult to answer. Based on the
fact that SLK cells establish latent expression patterns in the
absence of DNA methylation, and that BCBL1 and AP3 cells
maintain latency in spite of the lack of DNA methylation at the
ORF50 promoter, one may be tempted to think that this
epigenetic mark is of no fundamental importance during KSHV
latency. However, this is a conclusion which cannot be drawn.
Compared with SLKp cells, de novo infected SLK-5dpi cells indeed
display elevated levels of lytic gene expression and a higher
number of spontaneously reactivated cells (Figs. 5 and 9).
However, the generally low transcript levels together with the
scarcity of lytic cells even in SLK-5dpi cultures complicate any
general conclusion. Likewise, as the cells do not respond to
chemical treatment with reagents that induce the lytic cycle in
PEL cells, comparative studies of reactivation are difficult to
perform. Studies employing Rta overexpression (which can
reactivate such cells [38]) may be feasible, but they would be of
limited value as the ectopic expression would artificially override
one of the most critical steps of lytic reactivation. With regard to
PEL cells, more lines will have to be studied to conclude whether
absence or presence of methylation marks at the ORF50 promoter
has an impact on the percentage of spontaneously reactivated cells
and/or the response of such lines to chemical agents which induce
the lytic cycle. At present, although such differences certainly exist
between many PEL lines, this could in large part or entirely be a
consequence of host cell differences. Lastly, even if DNA
methylation should turn out to have no significant additive effect
over the presence of repressive histone marks in vitro, this may be
fundamentally different in vivo. Although the physiological triggers
which reactivate in vivo latency reservoirs (e.g. memory B cells) are
poorly understood, they are very likely to be much more specific
than the broad pleiotropic effects induced by chemical agents such
as phorbol esters or sodium butyrate. It is thus very conceivable
that DNA methylation may represent an additional, functionally
important block which augments repressive histone marks and re-
inforces latent expression patterns during long-term latency in vivo,
but which may be of lesser consequence in in vitro models of viral
infection.
Considering all of the above, many questions remain to be
answered before the molecular mechanisms which govern
establishment and maintenance of KSHV latency are fully
understood. However, especially given the unexpected spatial
and temporal patterns of histone modifications and DNA
methylation revealed by our study, the data presented here
provide important clues as to the host and viral factors which
might be at work, and should greatly help to design further studies
aimed at elucidating the role of epigenetic modifications during
this crucial phase of the viral lifecycle.
Materials and Methods
Cell culture and de novo KSHV infection
The establishment of SLKp cells has been described before
[39]. Briefly, endothelial SLK cells [60] were infected with KSHV
in vitro and passaged for several weeks. Seven KSHV-positive
single cell clones were selected from the long-term infected cultures
and pooled to form the SLKp line. SLKp cells and the parental
SLK line were cultured in DMEM supplemented with 10% fetal
calf serum and penicillin-streptomycin (5 mg/ml). The KSHV-
positive PEL cell lines BCBL1 [6], HBL6 [61] and AP3 [62] were
cultured in RPMI 1640 medium (Invitrogen) supplemented with
10% fetal calf serum and penicillin-streptomycin at a final
concentration of 5 mg/ml. Concentrated supernatants of infectious
KSHV virions were harvested from lytically induced BCBL1 cells
as described [39]. De novo infection of SLK cells was performed by
incubating 2610
5 cells at 70% confluency for 2 hrs with 500 ml
virus supernatant at a concentration of 1610
8 KSHV genome
equivalents per ml (as determined by quantitative PCR) in the
presence of 8 mg/ml polybrene in EGM-2 medium (Lonza).
Generally, more than 95% of cells were infected, as judged by
immunofluorescence analysis for LANA 48h after infection. For
lytic reactivation of BCBL1 cells, sodium butyrate was added to
the culture medium at a final concentration of 0.3 mM.
Immunofluorescence and western blot analysis
Cells were fixated with 4% paraformaldehyde in PBS for
15 min, permeabilized with 2% Triton X-100 in PBS for 10 min,
blocked with 3% BSA in PBS and incubated with primary
antibodies specific for LANA or ORF59 (Advanced Biotechnol-
ogies: #13-211-100) in blocking solution for 2 hrs. Cells were
washed three times with PBS and incubated with secondary
antibodies (Alexa Fluor-555 goat anti mouse and 2488 goat anti
rabbit) for another 2 hrs and analyzed by fluorescence microscopy.
Western blot analysis of total cell lysates was carried out by
standard SDS-PAGE and immunoblot protocols, using antibodies
directed against histone tri-methylated at lysine 27 (Upstate: #07-
449) or, as a loading control, actin (Santa Cruz: #SC-8432).
Retroviral expression of the H3K27 specific demethylase
JMJD3
A retroviral JMJD3 expression construct was kindly provided by
Paul Khavari [47]. The retroviral backbone MSCV (Clontech)
was used as a negative control. Supernatants containing infectious
viral particles were harvested 48 hrs post transfection of
PhoenixGP cells (Nolan Laboratory, http://www.stanford.edu/
group/nolan/). BCBL1 and SLK cells were transduced with
recombinant retroviruses by spin inoculation at 3006g for 1 h,
using undiluted supernatants in the presence of 8 mg/ml
polybrene. After inoculation, cultures were maintained in medium
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cells.
Analysis of CpG methylation by bisulfite sequencing and
COBRA
Bisulfite sequencing was performed using the EpiTect Bisulfite
Kit (Qiagen), following the manufacturer’s instructions. The
method relies on a chemical reaction that leads to the conversion
of all unmethylated cytosine residues to thymidines, allowing the
identification of originally methylated cytosines after PCR
amplification and sequencing of the locus of interest. The
sequences of all bisulfite sequencing primers employed in this
study are given in Table S1. PCR products were sequenced
directly (bulk sequencing) using either the forward or reverse
primer from the original amplification. CpG methylation patterns
were extracted from the bulk sequencing data using the BiQ
Analyzer v2.0 software [63]. A combined bisulfite restriction
analysis, short COBRA assay, has been described before [64].
Briefly, PCR products from bisulfite treated samples were digested
with the restriction enzyme TaqI (Fermentas) and resolved on an
agarose gel (3%). TaqI recognizes the nucleotide sequence TCGA,
which contains a CpG dinucleotide. After bisulfite conversion, the
site is only preserved if the original CpG motif was methylated
(note that the bisulfite conversion creates additional TaqI sites at
methylated CpG motifs which are flanked by C and A residues, as
the C in position 21 is converted to a T by the bisulfite reaction).
Isolation, reverse transcription and PCR quantitation of
RNA
RNA was isolated using the RNA-Bee (Tel-Test, Inc.) reagent.
Contaminating DNA was removed by incubation with amplifica-
tion grade DNase I (Invitrogen) and cDNA was prepared from
random-primed RNA using Superscript III (Invitrogen) as per the
manufacturer’s instructions. Real-time quantitative PCR (qPCR)
of cDNA or genomic DNA samples was performed using SensiMix
SYBR Kit (Quantace) on a Rotorgene 6000 light cycler (Corbett
Life Science). For quantitation, standard curves were created using
dilutions of genomic BCBL1 DNA over a range of at least
100006. The sequences of all primer pairs used in this study are
given in Table S1.
Chromatin Immunoprecipitation assay (ChIP)
ChIP analysis was performed as described by Si et al. [65] and
recommended by the array manufacturer (Agilent Mammalian
ChIP-on-chip protocol V10.0, May 2008), with some modifica-
tions. A detailed protocol of the procedure is given in Protocol S1.
Briefly, chromatin from 5610
6 to 2610
7 cells was cross-linked
with 1% formaldehyde. After quenching of the reaction by the
addition of glycine, cells were lysed and nuclei were isolated by
centrifugation. Chromatin was extracted from the isolated nuclei
and fragmented by sonication using a Bioruptor (Diagenode) to an
average length of 100–500 bp. A portion of the total chromatin
sample was set aside for the later preparation of input controls.
Material from 1610
6 cells was pre-cleared with salmon-sperm
DNA protein-A agarose beads (Upstate) to reduce non-specific
background and subjected to immunoprecipitation using 2 to
10 mg of antibodies specific for the histone modifications H3K9/
K14-Ac (Upstate: #06-599), H3K4-me3 (Upstate: #04-745),
H3K9-me3 (Upstate: #17-625) or H3K27-me3 (Upstate: #07-
449). After incubation for 16 hrs, chromatin-immunocomplexes
were precipitated by the addition of protein-A agarose, washed,
eluted and de-crosslinked overnight at 65uC. DNA was purified by
phenol-chloroform extraction and ethanol precipitation.
For preparation of input controls, 1/4
th of the amount of
chromatin used in the immunoprecipitation reactions was
employed. Input samples were treated in an identical manner as
the immunoprecipitated samples, starting with the de-crosslinking
step. Both samples were subsequently subjected to whole genome
amplification and labeling using a linker mediated PCR protocol
(Agilent Mammalian ChIP-on-chip protocol V10.0, May 2008),
followed by microarray hybridization.
Sequential ChIP assay
Colocalization of bivalent histone marks was measured by use of
a sequential ChIP assay. Prior to the first IP antibodies were
incubated with protein-A agarose beads (Upstate) for 2 hrs at 4uC.
Antibody bead complexes were washed twice with 0.2 M
triethanolamine buffer (Sigma). Beads and antibodies were
coupled covalently by incubation with 20 mM dimethyl pimeli-
midate dihydrochloride (DMP, Sigma) in 0.2 M triethanolamine
buffer on a rotating wheel for 30 min at RT, and the reaction was
stopped by washing with 50 mM Tris-HCl (pH 7.5). Uncoupled
antibodies were removed by pre-elution with 0.1 M acetic acid
(pH 3.0) for 5 min at RT. Beads were incubated with diluted
chromatin samples for 16 hrs at 4uC. Washing and elution was
performed in a identical manner as described above for the
standard ChIP assay. 1/16th of the precipitated chromatin was de-
crosslinked and was used to determine the efficiency of the first IP
by real-time qPCR. The remainder was employed as the input for
the second IP, which again was performed according to the
standard ChIP protocol. Results were calculated as percent of the
original input, i.e. the total amount of DNA which was subjected
to the first round of immunoprecipitation.
Methylated DNA Immunoprecipitation assay (MeDIP)
MeDIP analysis was essentially performed as described before
[35,66,67,68], with some modifications. A detailed protocol is
given in Protocol S2. Briefly, highly pure genomic DNA served as
an input in the MeDIP procedure. Negative and positive controls
were prepared by mixing genomic DNA from KSHV-negative
SLK cells with unmethylated or in vitro methylated KSHV bacmid
DNA [36], respectively. The ratio of viral vs. cellular DNA was
selected such that it mimics the episome content typically seen in
KSHV-infected PEL cell lines and the SLKp line (approx. 30–40
copies per cell). All DNA samples were sonicated to an average
fragment size of 100–500 bp using a Bioruptor (Diagenode). In
order to allow quantification and normalization of the data, a
constant amount (0.2 ng) of in vitro methylated pCR2.1 plasmid
was added per 5 mg of the sheared DNA. 1 mg of the sample was
set aside as an input control, and the remainder was subjected to
immunoprecipitation using 2.5 mgo fa5 9-methylcytidine specific
antibody (MAb-5MECYT-100, Diagenode). The precipitated
immunocomplexes were harvested using Dynabeads M-280 Sheep
anti-Mouse IgG (Invitrogen). After washing, DNA was eluted and
purified by phenol-chloroform extraction and ethanol precipita-
tion. Input control samples were treated identical to the IP
samples, starting with the ethanol precipitation step. The samples
were subsequently analyzed by qPCR and/or microarray
hybridization.
In vitro methylation of DNA
For control and normalization purposes, we prepared in vitro
methylated DNA from a bacmid containing the complete KSHV
genome [36] or the pCR2.1 vector (Invitrogen). DNA was
methylated by incubating 15 mg of DNA with 40 units of the
CpG methyltransferase M.SssI (NEB) for 2 hrs in 16NEBuffer 2
containing 160 mM S-adenosylmethionine (SAM). Fresh SAM was
Epigenetic Landscape of Latent KSHV Genomes
PLoS Pathogens | www.plospathogens.org 16 June 2010 | Volume 6 | Issue 6 | e1000935added and reactions were incubated for another 2 hrs. DNA was
purified and the reaction was repeated once to ensure complete
methylation. Complete methylation was confirmed by restriction
analysis using methylation sensitive enzymes (HpaII and MspI,
Fermentas), and/or bisulfite sequencing of specific loci.
Microarray design
Custom high-resolution KSHV microarrays were designed by
shifting a sequence window of 60 nt. across both strands of the
prototypic KSHV sequence (type P, accession number
NC_009333) as well as the terminal repeat unit (KSU86666).
Probes with a length between 45 and 60 nucleotides were selected
from these windows such that their melting temperature was close
to the optimal Tm of 80uC. To also ensure complete coverage of
type M KSHV strains, the resulting probe sets were aligned to the
type M reference sequence (NC_003409) and additional probes
were designed in a identical manner for all regions with a length of
80 or more nucleotides which were not already covered by the
original probe set. The length of all probes was subsequently
adjusted to 60 nucleotides using sequences from a common linker
(ATAACCGACGCCTAA), and each probe was synthesized in
duplicate on Agilent 8615k custom microarrays. For normaliza-
tion purposes, the array also contains probe sets which were
generated in an identical manner to cover the adenovirus type 5
genome (AY339865) as well as the pCR2.1 plasmid (Invitrogen).
Microarray sample labeling and hybridization
500 ng of MeDIP-input or ChIP-input controls, 500 ng of
immunoprecipitated ChIP material and all of the MeDIP material
were labeled with Cy3 and Cy5 using Agilent Genomic DNA
Labeling Kit PLUS according to Agilent’s recommendations. For
normalization purposes, 0.1 ng of Adenovirus Type 5 DNA were
added to each samples prior to the labeling procedure. After
labeling, samples were purified using Microcon YM-30 filter
columns (Milipore), blocked using Agilent blocking solution and
human cot-1 DNA (Invitrogen), and hybridized using the Agilent
Oligo aCGH/ChIP-on-chip Hybridization Kit at 65uC for 24 hrs
in a rotating oven. Arrays were washed once with Oligo aCGH/
ChIP-on-chip Wash Buffer 1 (Agilent 5188–5221) at RT for 5 min
and in Oligo aCGH/ChIP-on-chip Wash Buffer 2 (Agilent 5188–
5222) at 37uC for 1 min and scanned using a GenePix Personal
4100A scanner (Axon Instruments).
Microarray data analysis and normalization
Primary array analysis and data normalization was carried out
using GenePix Pro 6.0 software (Axon Instruments). All MeDIP
datasets were normalized using the methylated pCR2.1 plasmid
which had been added to the samples prior to the immunopre-
cipitation, thus controlling for differences in MeDIP efficiency as
well as labeling and array hybridization. Both channels were
adjusted such that the average ratio of input vs. MeDIP signals
across all pCR2.1-specific spots was 1. Similarly, ChIP datasets
were normalized using the adenovirus type 5 DNA that was added
as a spike-in prior to labeling, hence correcting for errors during
labeling, hybridization or scanning of the samples. To eliminate
false positive spots, we hybridized DNA from KSHV-negative
SLK cells and identified all probes which exhibited high levels of
background hybridization (i.e., fluorescence levels that exceeded
the mean value plus 16 the standard deviation of all KSHV-
specific spots on the negative control array). These probes (which
mapped almost exclusively to repeat regions) were permanently
flagged in all datasets and not used for further analysis. While our
arrays carry probes specific for the M and P types of the KSHV
genome, the KSHV genomes from the BCBL1 and AP3 lines have
not been fully sequenced and thus may deviate from the reference
genomes at a few locations. To control for such sequence
differences, we flagged all spots which exhibited fluorescence
levels which did not exceed a background fluorescence threshold
in the input channel, which was set to the mean fluorescence plus
twice the standard deviation of all negative control features (i.e.
empty array features as well as spots containing irrelevant
sequences, corresponding to all Agilent probes in the datasets
which are labeled with ‘‘NC2_’’ and ‘‘(-)3xSLv1’’). Note that, if
sequence diversification leads to only a reduction of hybridization
efficiency (e.g. due to single nucleotide polymorphism, which will
not abolish hybridization), this will not falsify our results as the
hybridization efficiency will be reduced in input as well as the
immunoprecipitated sample; the ratio will thus be unaffected.
In addition to above quality controls, in each dataset we flagged
all probes which exhibited more than 30% variance between
duplicate spots. The 30% threshold corresponds to the mean
variance plus twice the standard deviation exhibited by all KSHV-
specific probes in all MeDIP experiments, thus removing all
probes which show a significantly increased variance between
individual spot repeats. MeDIP data were furthermore corrected
by subtracting from each probe-specific signal the value observed
in the negative control, i.e. the MeDIP sample representing the
unmethylated KSHV bacmid in the background of cellular DNA.
After normalization, an enrichment score was calculated for each
of the probes, represented by the ratio of fluorescence signal
intensities in the immunoprecipitated samples relative to the input
control. As the average length of the immunoprecipitated MeDIP
and ChIP fragments (100 to 500 bp) is greater than that of the
tiled probes (45 to 60 nucleotides), the resolution of our analysis
was limited by the fragment length rather than the array design.
To account for this fact, the data presented in Figures 2 to 6, 7 and
8 were calculated by tiling overlapping sequence windows of 250
nucleotides across the KSHV genome, using a step size of 100
nucleotides to advance each window. The type M reference
sequence (NC_003409) was used for the HBL6 line, whereas the
type P genome (NC_009333) was used for all other cells. The
KSHV specific probes were subsequently blasted against the
window sequences, and each window was awarded an enrichment
score represented by the average score of all probes which showed
more than 90% identity with either strand of its sequence. All
scores (which were also used to calculate the Pearson correlation
coefficients presented in Tables 1 and 2) are given in the Dataset
S1. All raw data, including the original GPR files as well as
sequence and match location(s) of individual probes are available
from the Gene Expression Omnibus (GEO) Database at http://
www.ncbi.nlm.nih.gov/geo, under accession number GSE19907.
Supporting Information
Table S1 KSHV-specific PCR primers used in this study.
Found at: doi:10.1371/journal.ppat.1000935.s001 (0.08 MB
DOC)
Protocol S1 ChIP Protocol.
Found at: doi:10.1371/journal.ppat.1000935.s002 (0.03 MB
DOC)
Protocol S2 MeDIP Protocol.
Found at: doi:10.1371/journal.ppat.1000935.s003 (0.04 MB
DOC)
Dataset S1 Dataset containing all datapoints used for Figures 2
to 6, 7 and 8, and for the calculation of correlation coefficients
given in Tables 1 and 2.
Found at: doi:10.1371/journal.ppat.1000935.s004 (0.60 MB XLS)
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genomes (Higher magnification of data presented in Figure 2).
Found at: doi:10.1371/journal.ppat.1000935.s005 (0.50 MB PDF)
Figure S2 Global patterns of H3K9/K14 Acetylation and
H3K4 tri-methylation on latent KSHV genomes (Higher
magnification of data presented in Figure 6).
Found at: doi:10.1371/journal.ppat.1000935.s006 (0.41 MB PDF)
Figure S3 Global patterns of H3K27 and H3K9 tri-methylation
on latent KSHV genomes (Higher magnification of data presented
in Figure 7).
Found at: doi:10.1371/journal.ppat.1000935.s007 (0.44 MB PDF)
Figure S4 Spontaneous reactivation in BCBL1 cells. BCBL1
cells were analyzed by immunofluorescence for the expression of
the ORF59 gene product. A phase contrast image (PC) is shown to
the left, and an enlarged overlay of the section framed by the white
rectangle is shown at the bottom.
Found at: doi:10.1371/journal.ppat.1000935.s008 (3.17 MB TIF)
Figure S5 Rta binding sites and global patterns of H3K4-me3
on latent KSHV genomes. H3K4 tri-methylation (H3K4-me3)
patterns in BCBL1, SLKp cells as well as SLK cultures at 5 days
post infection (SLK-5dpi) are shown as described in the legend to
Figure 6. The location of regions which were found to harbor Rta
binding sites in genome-wide screens performed by Chen et al.
[48] or Ellison et al. [24] is indicated by dotted lines. The labeling
above the lines indicates whether these regions were identified by
Chen et al. (labelled ‘‘1’’), Ellison et al. (‘‘2’’), or in both studies
(‘‘1,2’’).
Found at: doi:10.1371/journal.ppat.1000935.s009 (1.02 MB TIF)
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